Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules

WASHINGTON (Reuters) - Pfizer Inc'sbuyout bid for Allergan Plchas financial markets on edge over a possible new move by the U.S. Treasury Department against tax-inversion deals, but the outlook...